Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007969 · ClinicalTrials.gov registry record · Phase 1
Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
A Phase 1 study, sponsored by QLT.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00007969: Completed Phase 1 study, sponsored by QLT.
NCT00007969 is a Phase 1 study that has completed, run by QLT. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007969, a Phase 1 study, has completed, sponsored by QLT.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy may be effective in treating melanoma. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy in treating patients who have stage III or stage IV melanoma.
Interventions
- DRUG verteporfin
- BIOLOGICAL Detox-B adjuvant
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 1 |
What the finished NCT00007969 record still lists
NCT00007969 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which verteporfin is the first listed.
NCT00007969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00007969 about?
NCT00007969 is a clinical study titled "Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma". RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy may be effective in treating melanoma. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy in treating patients who have stage III o...
What is the current status of trial NCT00007969?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-10.
What interventions are being tested in trial NCT00007969?
The interventions under investigation include: verteporfin (DRUG), Detox-B adjuvant (BIOLOGICAL).
Who is sponsoring clinical trial NCT00007969?
This trial is sponsored by QLT, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia